Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS"). The 2nd SCIIS aims.
/PRNewswire/ Kessler Foundation has received $3,000,000 from the Social Security Administration s (SSA) Interventional Cooperative Agreement Program (ICAP).
Kessler Foundation awarded Social Security Administration funding to expand research for improving employment outcomes following neurotrauma streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.